Topic: Pbms

Robert F. Kennedy Jr. explains the Trump administration's plan to bring U.S. drug prices down to European levels by eliminating Pharmacy Benefit Managers (PBMs). He cites the example of Ozempic, which costs $1,300 in the U.S. but only $88 in London, as evidence of the pharmaceutical lobby's power. Kennedy asserts that the administration is prepared to take escalating steps if drug companies do not cooperate with the new executive orders.

Brigham Bueller details his experience as a drug rep and his realization that antidepressants often perform no better than placebos. He explains the role of Pharmacy Benefit Managers (PBMs) in driving up drug costs and monetizing chronic disease. Robert F. Kennedy Jr. and Tulsi Gabbard are highlighted as leaders working to dismantle this "corporate capture" of the healthcare system.

The "Make America Healthy Again" (MAHA) movement aims to expose "spread pricing" and other deceptive practices by insurance holding companies. UnitedHealthcare reportedly made $365 billion last year, with a majority of revenue coming from prescription drug markups. Brigham Bueller expresses hope that the new administration will finally bring transparency to these predatory financial structures.